janssen science wordmark
Health equity

Health equity

Hub to enterprise-wide information and initiatives that support innovation in the areas of diversity, equity, and inclusion

 

My health can't wait

My Health Can’t Wait is a community wellness initiative designed to help patients and caregivers manage their health through increased access to vital information and resources. My Health Can’t Wait sponsors community wellness events across the country that can be accessed here.

 

Our race to health equity

Johnson & Johnson aspires to help eradicate racial and social injustice as a public health threat by eliminating health inequities for people of color. The Company commits $100 million over the next five years to invest and promote health equity solutions.

 

Independent educational grant: CME focus on diversity, equity, and inclusion

Johnson & Johnson aspires to help eradicate racial and social injustice as a public health threat by eliminating health inequities for people of color through the Race to Health Equity initiative. Johnson & Johnson is committed to invest in and promote health equity solutions. As part of this initiative and in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Addresses Population Health accreditation criteria, Johnson & Johnson is proud to support independent medical educational programs that address and/or incorporate diversity, equity, and inclusion. 

 

LABS quickfire challenge

Grant funding program accepting applications for new and innovative ideas with the potential to provide solutions to patients and consumers across the world including grants focused on advancing health equity, impacting BIPOC (Black, Indegenious, People of Color) communities, underrepresented or diverse people in STEM careers

 

Health equity innovation challenge

Program invested in community-based solutions developed for the community by the community to seek and accelerate innovations that have the potential to advance health equity

 

You belong: diversity & inclusion impact review

Advancing a culture of belonging where open hearts and minds combine to unleash the potential of the brilliant mix of people, in every corner of Johnson & Johnson

 

Employee resource groups

Johnson & Johnson Employee Resource Groups (ERGs) are voluntary, employee-led groups that focus on shared identities/affinities and experiences, and that look to apply those perspectives to initiatives that create value for all of Johnson & Johnson. These enterprise-wide ERGs are uniquely positioned to provide key insights—ultimately driving better outcomes on behalf of our people, our marketplace and our communities. They enable Johnson & Johnson to attract and retain diverse talent, provide employee leadership development opportunities, and support several community patient initiatives to drive greater health and wellness education for all. ERGs also contribute to advancing Johnson & Johnson culture of belonging by fostering employee engagement, which positively impacts business outcomes.

 

Health and humanity report

The Health and Humanity Report details the progress of the Johnson & Johnson Family of Companies in sustainability, including a focus on global health equity. This report also is the primary source of annual disclosure on environmental, social and governance (ESG) performance and should be reviewed in conjunction with disclosures on the ESG Policies & Positions page

 

Patient education research councils - qualitative research on patient perceptions of motivators and barriers to research participation across race/ethnicity

The lack of racial/ethnic diversity in research potentially limits the generalizability of findings to a broader population, highlighting the need for greater diversity and inclusion in clinical research. Focus groups were conducted with 26 participants from Janssen's Patient Engagement Research Councils to identify (i) the potential motivators and barriers to study participation across different races and ethnicities; (ii) preferred delivery of education and information to support healthcare decision-making and the role of the community. This study provided insights into barriers to study participation, and also highlighted the need for pharmaceutical companies and other entities to authentically engage in strategies that build trust within communities to enhance recruitment among diverse populations.

 

Initiatives across janssen pharmaceutical companies in the areas of health equity